263 | 0 | 16 |
下载次数 | 被引频次 | 阅读次数 |
目的 从滤泡辅助性T (Tfh)细胞和Janus激酶/信号转导与转录激活因子(JAK/STAT)通路探讨活血消异方治疗卵巢型子宫内膜异位症的可能作用机制。方法 使用GEO数据库下载人类增殖期子宫内膜异位症异位组织与正常女性增殖期的子宫组织测序数据。将具有正常动情周期的45只雌性SD大鼠随机分为活血消异方组、模型组和正常组,每组15只。采用异位组织插入法建立卵巢型子宫内膜异位症大鼠模型,造模成功后活血消异方组予活血消异方溶液5.85 g/(kg·d)灌胃,模型组和正常组予生理盐水1 ml/d灌胃,均连续14天。采用转录组学技术测序分析各组大鼠卵巢异位组织和正常子宫组织的基因表达情况,与人类数据进行比较,以探讨增殖期异位组织中JAK/STAT通路激活情况,使用免疫组化法检测大鼠卵巢异位组织和正常子宫组织中CXC趋化因子受体5(CXCR5)、白细胞介素21(IL-21)阳性表达,Western Blot法检测IL-21、白细胞介素21受体(IL-21R)、Janus激酶1 (JAK1)、信号转导与转录激活因子6 (STAT6)、B淋巴细胞瘤2(Bcl-2)蛋白水平,免疫浸润法分析滤泡辅助性T (Tfh)细胞情况。结果 通过基因集富集分析发现,与正常子宫组织比较,人类增殖期子宫内膜异位症异位组织JAK/STAT通路被明显激活。与正常组比较,模型组大鼠卵巢异位组织中JAK/STAT通路被明显激活;与模型组比较,活血消异方组大鼠卵巢异位组织中JAK/STAT通路被抑制。与正常组子宫组织比较,模型组卵巢异位组织中Tfh细胞组分评分,IL-21及CXCR5阳性表达,IL-21、IL-21R、JAK1、STAT6及Bcl-2蛋白水平均升高(P<0.05);与模型组比较,活血消异方组卵巢异位组织中IL-21及CXCR5阳性表达,IL-21、IL-21R、JAK1、STAT6及Bcl-2蛋白水平均降低(P<0.05)。结论 活血消异方可能通过抑制Tfh细胞分泌IL-21来抑制卵巢型子宫内膜异位症模型大鼠异位组织中JAK/STAT通路的激活,从而发挥治疗卵巢型子宫内膜异位症的作用。
Abstract:Objective To explore the potential mechanism of Huoxue Xiaoyi Formula (活血消异方, HXF) in treating ovarian endometriosis(OEM) from the perspective of T follicular helper(Tfh) cells and the Janus kinase/signal transducer and activator of transcription(JAK/STAT) signaling pathway. Methods Forty-five female SD rats with normal estrous cycles were randomly divided into three groups, HXF group, model group, and normal group, with 15 rats in each group. A rat model of OEM was established by autologous endometrial tissue implantation.After successful modeling, the treatment group received HXF at 5. 85 g/(kg·d) by gavage for 14 consecutive days.The model group and normal group received 1 mL/d of normal saline by gavage. RNA-sequencing data from human proliferative-phase endometriotic and normal endometrial tissues were downloaded from the GEO database. Transcriptomic sequencing was used to analyze gene expression in rat ovarian ectopic tissues and normal uterine tissues, and comparisons were made with human data to verify JAK/STAT pathway activation in proliferative-phase ectopic tissues.Immunohistochemistry was used to detect the positive expression of CXC chemokine receptor 5(CXCR5) and interleukin-21(IL-21) in rat ovarian ectopic and normal uterine tissues. Western Blotting was performed to detect the protein levels of IL-21, IL-21 receptor(IL-21R), Janus kinase 1(JAK1), signal transducer and activator of transcription 6(STAT6), and B-cell lymphoma 2(Bcl-2). Tfh cell infiltration was analyzed using immune cell infiltration methods. Results Gene set enrichment analysis showed that the JAK/STAT pathway was significantly activated in human proliferativephase endometriotic tissues compared to normal endometrial tissues. Similarly, the JAK/STAT pathway was markedly activated in rat ovarian ectopic tissues in the model group compared to the normal group, but suppressed in the HXF group compared to the model group. Compared with normal uterine tissues, ovarian ectopic tissues in the model group showed increased Tfh cell infiltration scores, higher CXCR5 and IL-21 expression, and elevated levels of IL-21, IL-21R, JAK1, STAT6, and Bcl-2 proteins. Compared with the model group, HXF group showed reduced CXCR5and IL-21 expression and decreased protein levels of IL-21, IL-21R, JAK1, STAT6, and Bcl-2. Conclusion HXF may suppress activation of the JAK/STAT signaling pathway in ovarian endometriotic tissues by inhibiting IL-21 secretion from Tfh cells.
[1]BONAVINA G, TAYLOR HS. Endometriosis-associated infertility:from pathophysiology to tailored treatment[J].Front Endocrinol(Lausanne), 2022,13:1020827. doi:10. 3389/fendo. 2022. 1020827.
[2]VERCELLINI P, VIGANòP, SOMIGLIANA E,et al.Endometriosis:pathogenesis and treatment[J]. Nat Rev Endocrinol,2014,10(5):261-275.
[3]周华,齐聪.补肾活血法治疗复发性卵巢子宫内膜异位囊肿30例临床观察[J].中医杂志,2008,49(7):618-621.
[4]梁齐桁,程兰,钟庭开.中医慢病管理模式下卵巢子宫内膜异位症术后复发及妊娠情况观察[J].山东医药,2022,62(17):73-75.
[5]DING D, LIU S, LIU F, et al. Exploring the role of Chinese herbal medicine in the long-term management of postoperative ovarian endometriotic cysts:a systematic review and meta-analysis[J]. Front Pharmacol,2024,15:1376037. doi:10. 3389/fphar. 2024. 1376037.
[6]李田田,赵双俏,文胜,等.活血消异方治疗气滞血瘀型卵巢子宫内膜异位囊肿临床观察[J].现代中西医结合杂志,2018,27(5):484-487,549.
[7]张玉,张永嘉,赵瑞华,等.子宫内膜异位症痛经症状特点及活血消异方疗效分析[J].时珍国医国药,2022,33(9):2176-2178.
[8]张永嘉,刘永,时光,等.活血消异方加减治疗子宫内膜异位症伴抑郁焦虑患者的临床观察[J].中国中西医结合杂志,2021,41(7):873-876.
[9]王娜娜,赵瑞华,夏文艳.活血消异方抑制盆腔子宫内膜异位症保守术后复发的病例研究[J].中华中医药杂志,2017,32(8):3861-3864.
[10]YANG XC, LIU Y, SUN WW, et al. Efficacy of Chinese herbal medicines on pregnancy outcomes in patients with endometriosis in long-term management:a multicenter retrospective cohort study[J]. Chin J Integr Med,2023,29(11):971-979.
[11]KOTLYAR AM, MAMILLAPALLI R, FLORES VA,et al. Tofacitinib alters STAT3 signaling and leads to endometriosis lesion regression[J]. Mol Hum Reprod,2021,27(4):gaab016.
[12]陈颖,仇茜,许琳玲,等.滤泡辅助性T细胞CD4+T细胞的表达与子宫内膜异位症伴不孕症患者发病及自身抗体的相关性[J].中国性科学,2022,31(6):62-65.
[13]CHEN B, LIU Y, CHENG L. IL-21 enhances the degradation of cartilage through the JAK-STAT signaling pathway during osteonecrosis of femoral head cartilage[J].Inflammation,2018,41(2):595-605.
[14]FAN W, ZHANG Y, DAI Y, et al. Creation of a rat model of ovarian endometriosis:a novel and easy approach to simulating chocolate cysts[J]. Exp Cell Res,2025,448(1):114553.
[15]时光,杨新春,崔景润,等.活血消异方对子宫内膜异位症大鼠卵巢功能及妊娠结局的影响研究[J].北京中医药大学学报,2024,47(3):374-382.
[16]魏伟,吴希美,李元建.药理实验方法学[M].北京:人民卫生出版社,2010:69-72.
[17]KIM D, LANGMEAD B, SALZBERG SL. HISAT:a fast spliced aligner with low memory requirements[J].Nat Methods,2015,12(4):357-360.
[18]PERTEA M, PERTEA GM, ANTONESCU CM, et al.StringTie enables improved reconstruction of a transcriptome from RNA-seq reads[J]. Nat Biotechnol, 2015,33(3):290-295.
[19]LI B, DEWEY CN. RSEM:accurate transcript quantification from RNA-Seq data with or without a reference genome[J]. BMC Bioinformatics,2011,12:323. doi:10.1186/1471-2105-12-323.
[20]LI L, LI L, SUN Q. High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer:an analysis based on public databases[J]. BMC Bioinformatics,2022,23(1):350.
[21]HE Y, WU Y, LIU Z, et al. Identification of signature genes associated with invasiveness and the construction of a prognostic model that predicts the overall survival of bladder cancer[J]. Front Genet,2021,12:694777. doi:10. 3389/fgene. 2021. 694777.
[22]YANG Q, CHU W, YANG W, et al. Identification of RNA transcript makers associated with prognosis of kidney renal clear cell carcinoma by a competing endogenous RNA network analysis[J]. Front Genet,2020,11:540094. doi:10. 3389/fgene. 2020. 540094.
[23]秦翠梅,聂晓博,王炎,等.基于JAK 2/STAT 3信号通路探讨三棱莪术及配伍干预大鼠子宫内膜异位症的配伍研究[J].中药药理与临床,2022,38(1):134-139.
[24]单婧,程雯,翟东霞,等.子宫内膜异位症啮齿类动物模型研究进展[J].生殖医学杂志,2017,26(5):498-501.
[25]HAYASHI S, NAKAMURA T, MOTOOKA Y,et al.Novel ovarian endometriosis model causes infertility via iron-mediated oxidative stress in mice[J]. Redox Biol,2020,37:101726. doi:10. 1016/j. redox. 2020. 101726.
[26]时光,刘永,孙伟伟,等.中药活血补肾序贯治疗对子宫内膜异位症大鼠卵泡发育与颗粒细胞凋亡的影响[J].中华中医药杂志,2019,34(5):2155-2159.
[27]王新,吴建林,石雅馨,等.从“瘀、毒、痰湿”谈子宫内膜异位症之病机与治疗[J].中国中医基础医学杂志,2022,28(7):1160-1163,1167.
[28]范伟森,刘姣,张英杰,等.中医药治疗子宫内膜异位症的相关通路研究进展[J].中国实验方剂学杂志,2023,29(3):233-243.
[29]FU G, GUY CS, CHAPMAN NM, et al. Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine[J]. Nature, 2021,595(7869):724-729.
[30]AHEARNE MJ, WILLIMOTT S, PI?ON L,et al. Enhancement of CD154/IL4 proliferation by the T follicular helper(Tfh)cytokine, IL-21 and increased numbers of circulating cells resembling Tfh cells in chronic lymphocytic leukaemia[J]. Br J Haematol,2013,162(3):360-370.
基本信息:
DOI:10.13288/j.11-2166/r.2025.14.011
中图分类号:R285.5;R-332
引用信息:
[1]范伟森,张永嘉,王雅倩等.活血消异方对卵巢型子宫内膜异位症模型大鼠异位组织中Tfh细胞及JAK/STAT通路的影响[J].中医杂志,2025,66(14):1473-1480.DOI:10.13288/j.11-2166/r.2025.14.011.
基金信息:
国家自然科学基金(82374513,82074485); 北京市重大疑难疾病中西医协同攻关项目(2023BJSZDYNJBXTGG-009)